Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents

Recent review on selective histone deacetylase inhibitors in cancer therapy

Recent Prospectives of Anticancer Histone Deacetylase Inhibitors

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms

Effect of Sulforaphane and Methotrexate combined treatment on Histone Deacetylase Activity in Solid Ehrlich Carcinoma

Coumarin based-histone deactylace HADC inhibitors

Epigenetics in Hematological Malignancies

COMPARING ANTIPROLIFERATIVE AND PROAPOPTOTIC EFFECTS OF THE PAN-DEACETYLASE INHIBITOR PANOBINOSTAT WITH DOXORUBICIN ON HEPG2 HEPATOCELLULAR CARCINOMA CELL LINE